Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2017. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3332426015 | Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3333582014 | R-CHOP chemotherapy regimen | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
3333587015 | Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3334373012 | R-CHOP chemotherapy protocol | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | Antineoplastic chemotherapy regimen | true | Inferred relationship | Existential restriction modifier | ||
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 5 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 6 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 7 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Direct substance | Prednisone | true | Inferred relationship | Existential restriction modifier | 7 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 8 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 9 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Direct substance | Vincristine | true | Inferred relationship | Existential restriction modifier | 5 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Direct substance | Cyclophosphamide | true | Inferred relationship | Existential restriction modifier | 8 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Direct substance | Doxorubicin | true | Inferred relationship | Existential restriction modifier | 9 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Direct substance | Rituximab | true | Inferred relationship | Existential restriction modifier | 6 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | Cyclophosphamide therapy | true | Inferred relationship | Existential restriction modifier | ||
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | Rituximab therapy | true | Inferred relationship | Existential restriction modifier | ||
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | Corticosteroid and/or corticosteroid derivative therapy | true | Inferred relationship | Existential restriction modifier | ||
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Has intent | Therapeutic intent | true | Inferred relationship | Existential restriction modifier | 3 | |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | Antibiotic therapy | false | Inferred relationship | Existential restriction modifier | ||
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | Anthracycline therapy | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets